Treating peripheral arterial disease (PAD) with novel devices not only reveals good clinical outcomes, but continues to attract the investment community.
Six-month results of DISRUPT PAD, a 35-patient study of Shockwave Medical Inc.’s Lithoplasty balloon catheter, were presented in April...